Ironwood Pharmaceuticals IncNASDAQ:IRWD
- LAST PRICE5.8300
- TODAY'S CHANGE (%)-0.1500 (-2.5084%)
- Bid / Lots5.5200/ 3
- Ask / Lots6.0400/ 1
- Open / Previous Close5.9400 / 5.9800
- Day Range
- 52 Week Range
- Volume2,351,012
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IRWD |
|---|---|---|
| 09:32 ET | 23680 | 5.83 |
| 09:34 ET | 2302 | 5.83 |
| 09:36 ET | 2169 | 5.81 |
| 09:38 ET | 3812 | 5.79 |
| 09:39 ET | 1846 | 5.77 |
| 09:41 ET | 11134 | 5.72 |
| 09:43 ET | 59732 | 5.74 |
| 09:45 ET | 2491 | 5.75 |
| 09:48 ET | 20125 | 5.76 |
| 09:50 ET | 5178 | 5.75 |
| 09:52 ET | 4066 | 5.75 |
| 09:54 ET | 11611 | 5.75 |
| 09:56 ET | 5600 | 5.75 |
| 09:57 ET | 12479 | 5.765 |
| 09:59 ET | 524 | 5.765 |
| 10:01 ET | 4232 | 5.755 |
| 10:03 ET | 6697 | 5.745 |
| 10:06 ET | 28571 | 5.725 |
| 10:08 ET | 5212 | 5.735 |
| 10:10 ET | 5148 | 5.75 |
| 10:12 ET | 300 | 5.74 |
| 10:14 ET | 20746 | 5.73 |
| 10:15 ET | 1755 | 5.735 |
| 10:17 ET | 1808 | 5.75 |
| 10:19 ET | 5814 | 5.7 |
| 10:21 ET | 10691 | 5.72 |
| 10:24 ET | 11529 | 5.735 |
| 10:26 ET | 4840 | 5.7201 |
| 10:28 ET | 17865 | 5.75 |
| 10:30 ET | 1100 | 5.765 |
| 10:32 ET | 7309 | 5.755 |
| 10:33 ET | 3087 | 5.76 |
| 10:35 ET | 1595 | 5.755 |
| 10:37 ET | 3924 | 5.735 |
| 10:39 ET | 2640 | 5.755 |
| 10:42 ET | 1429 | 5.765 |
| 10:44 ET | 4711 | 5.76 |
| 10:46 ET | 2554 | 5.77 |
| 10:48 ET | 9541 | 5.805 |
| 10:50 ET | 2251 | 5.825 |
| 10:51 ET | 2181 | 5.82 |
| 10:53 ET | 3773 | 5.795 |
| 10:55 ET | 421 | 5.79 |
| 10:57 ET | 5508 | 5.805 |
| 11:00 ET | 3173 | 5.8 |
| 11:02 ET | 100 | 5.8 |
| 11:04 ET | 4810 | 5.825 |
| 11:06 ET | 1936 | 5.815 |
| 11:08 ET | 1850 | 5.805 |
| 11:09 ET | 2696 | 5.8 |
| 11:11 ET | 1286 | 5.81 |
| 11:13 ET | 6825 | 5.81 |
| 11:15 ET | 8943 | 5.825 |
| 11:18 ET | 4280 | 5.82 |
| 11:20 ET | 3193 | 5.81 |
| 11:22 ET | 1926 | 5.81 |
| 11:24 ET | 15952 | 5.815 |
| 11:26 ET | 1009 | 5.825 |
| 11:27 ET | 9623 | 5.825 |
| 11:29 ET | 4042 | 5.83 |
| 11:31 ET | 7566 | 5.845 |
| 11:33 ET | 4565 | 5.845 |
| 11:36 ET | 7783 | 5.85 |
| 11:38 ET | 1718 | 5.85 |
| 11:40 ET | 2356 | 5.855 |
| 11:42 ET | 2707 | 5.835 |
| 11:44 ET | 1600 | 5.825 |
| 11:45 ET | 400 | 5.82 |
| 11:47 ET | 5479 | 5.835 |
| 11:49 ET | 2015 | 5.84 |
| 11:51 ET | 6623 | 5.835 |
| 11:54 ET | 3812 | 5.829 |
| 11:56 ET | 915 | 5.82 |
| 11:58 ET | 5905 | 5.82 |
| 12:00 ET | 12030 | 5.85 |
| 12:02 ET | 308 | 5.85 |
| 12:03 ET | 1850 | 5.83 |
| 12:05 ET | 900 | 5.83 |
| 12:07 ET | 400 | 5.83 |
| 12:09 ET | 2972 | 5.82 |
| 12:12 ET | 814 | 5.825 |
| 12:14 ET | 200 | 5.82 |
| 12:16 ET | 2613 | 5.82 |
| 12:18 ET | 200 | 5.82 |
| 12:20 ET | 1000 | 5.82 |
| 12:21 ET | 8538 | 5.83 |
| 12:23 ET | 602 | 5.835 |
| 12:25 ET | 602 | 5.835 |
| 12:27 ET | 1251 | 5.83 |
| 12:30 ET | 5814 | 5.83 |
| 12:32 ET | 1102 | 5.83 |
| 12:34 ET | 8151 | 5.845 |
| 12:36 ET | 200 | 5.84 |
| 12:38 ET | 3597 | 5.84 |
| 12:39 ET | 8068 | 5.845 |
| 12:41 ET | 1527 | 5.845 |
| 12:43 ET | 611 | 5.84 |
| 12:45 ET | 931 | 5.84 |
| 12:48 ET | 1038 | 5.83 |
| 12:50 ET | 1029 | 5.83 |
| 12:52 ET | 7240 | 5.85 |
| 12:54 ET | 210 | 5.855 |
| 12:56 ET | 800 | 5.85 |
| 12:57 ET | 2757 | 5.8401 |
| 12:59 ET | 882 | 5.845 |
| 01:01 ET | 389 | 5.845 |
| 01:03 ET | 1828 | 5.83 |
| 01:06 ET | 400 | 5.83 |
| 01:08 ET | 430 | 5.83 |
| 01:10 ET | 595 | 5.83 |
| 01:12 ET | 7045 | 5.85 |
| 01:14 ET | 939 | 5.84 |
| 01:15 ET | 8010 | 5.845 |
| 01:17 ET | 716 | 5.84 |
| 01:19 ET | 200 | 5.8467 |
| 01:21 ET | 7708 | 5.83 |
| 01:24 ET | 13082 | 5.835 |
| 01:26 ET | 1215 | 5.835 |
| 01:28 ET | 800 | 5.835 |
| 01:30 ET | 8309 | 5.835 |
| 01:32 ET | 1306 | 5.83 |
| 01:33 ET | 499 | 5.83 |
| 01:35 ET | 601 | 5.835 |
| 01:37 ET | 200 | 5.83 |
| 01:39 ET | 12214 | 5.83 |
| 01:42 ET | 5795 | 5.825 |
| 01:44 ET | 3606 | 5.825 |
| 01:46 ET | 15020 | 5.85 |
| 01:48 ET | 910 | 5.85 |
| 01:50 ET | 1364 | 5.855 |
| 01:51 ET | 1209 | 5.85 |
| 01:53 ET | 4382 | 5.85 |
| 01:55 ET | 6166 | 5.855 |
| 01:57 ET | 2677 | 5.845 |
| 02:00 ET | 983 | 5.84 |
| 02:02 ET | 8079 | 5.845 |
| 02:04 ET | 2979 | 5.845 |
| 02:06 ET | 400 | 5.84 |
| 02:08 ET | 3680 | 5.83 |
| 02:09 ET | 2250 | 5.83 |
| 02:11 ET | 12121 | 5.85 |
| 02:13 ET | 600 | 5.855 |
| 02:15 ET | 3654 | 5.875 |
| 02:18 ET | 1721 | 5.875 |
| 02:20 ET | 6310 | 5.865 |
| 02:22 ET | 5992 | 5.855 |
| 02:24 ET | 4444 | 5.865 |
| 02:26 ET | 3781 | 5.855 |
| 02:27 ET | 1034 | 5.85 |
| 02:29 ET | 675 | 5.85 |
| 02:31 ET | 3357 | 5.85 |
| 02:33 ET | 1578 | 5.85 |
| 02:36 ET | 2545 | 5.84 |
| 02:38 ET | 704 | 5.84 |
| 02:40 ET | 11508 | 5.85 |
| 02:42 ET | 1430 | 5.85 |
| 02:44 ET | 600 | 5.845 |
| 02:45 ET | 2464 | 5.84 |
| 02:47 ET | 1285 | 5.84 |
| 02:49 ET | 1893 | 5.84 |
| 02:51 ET | 1178 | 5.84 |
| 02:54 ET | 1270 | 5.84 |
| 02:56 ET | 1649 | 5.84 |
| 02:58 ET | 2962 | 5.84 |
| 03:00 ET | 17979 | 5.855 |
| 03:02 ET | 640 | 5.85 |
| 03:03 ET | 635 | 5.85 |
| 03:05 ET | 801 | 5.85 |
| 03:07 ET | 1503 | 5.85 |
| 03:09 ET | 1765 | 5.85 |
| 03:12 ET | 7056 | 5.84 |
| 03:14 ET | 6135 | 5.84 |
| 03:16 ET | 3545 | 5.84 |
| 03:18 ET | 11378 | 5.84 |
| 03:20 ET | 5024 | 5.83 |
| 03:21 ET | 4177 | 5.83 |
| 03:23 ET | 14906 | 5.84 |
| 03:25 ET | 4791 | 5.84 |
| 03:27 ET | 14430 | 5.835 |
| 03:30 ET | 44239 | 5.855 |
| 03:32 ET | 2024 | 5.85 |
| 03:34 ET | 11556 | 5.84 |
| 03:36 ET | 6200 | 5.845 |
| 03:38 ET | 4602 | 5.84 |
| 03:39 ET | 26747 | 5.865 |
| 03:41 ET | 12055 | 5.855 |
| 03:43 ET | 19457 | 5.84 |
| 03:45 ET | 10685 | 5.835 |
| 03:48 ET | 10536 | 5.83 |
| 03:50 ET | 15158 | 5.83 |
| 03:52 ET | 14003 | 5.835 |
| 03:54 ET | 46288 | 5.82 |
| 03:56 ET | 20745 | 5.81 |
| 03:57 ET | 62949 | 5.8 |
| 03:59 ET | 615044 | 5.83 |
Jun 11, 2024
Jun 8, 2024
Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch, from 11:04AM ET on Saturday Jun 08, 2024 by Dow Jones
11:04AM ET on Saturday Jun 08, 2024 by Dow Jones
Jun 7, 2024
Jun 6, 2024
Jun 5, 2024
Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect, from 1:34PM ET on Wednesday Jun 05, 2024 by Dow Jones
1:34PM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ironwood Pharmaceuticals Inc | 926.7M | -0.9x | --- |
Sinovac Biotech Ltd | 639.9M | -6.0x | --- |
Organogenesis Holdings Inc | 330.8M | 57.4x | --- |
MiMedx Group Inc | 1.0B | 18.1x | --- |
BioCryst Pharmaceuticals Inc | 1.3B | -5.8x | --- |
Catalyst Pharmaceuticals Inc | 1.8B | 28.0x | --- |
Company Information
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years old. It is advancing apraglutide, a long-acting synthetic glucagon-like peptide-2 (GLP-2) analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF) as well as several earlier stage assets. It is advancing IW-3300, a GC-C agonist, for the potential treatment of visceral pain conditions, such as interstitial cystitis/bladder pain syndrome (IC/BPS), and endometriosis. It is also developing CNP-104 for the treatment of PBC, a rare autoimmune disease targeting the liver.
Contact Information
- Headquarters
- 100 Summer Street, Suite 2300BOSTON, MA, United States 02110
- Phone
- 617-621-7722
- Fax
- 617-494-0480
Executives
- Independent Chairman of the Board
- Julie Mchugh
- Chief Executive Officer, Director
- Thomas Mccourt
- Senior Vice President, Chief Financial Officer
- Sravan Emany
- Senior Vice President, Chief Legal Officer, Secretary
- John Minardo
- Senior Vice President, Chief Business Officer
- Andrew Davis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $926.7M |
|---|---|
Revenue (TTM) | $413.6M |
Shares Outstanding | 159.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.51 |
EPS | $-6.79 |
Book Value | $-2.21 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -240.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
